We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IBKR:NASDAQInteractive Brokers Group, Inc. Analysis

Data as of 2026-08-14 - not real-time

$92.06

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Interactive Brokers Group, Inc. is neutral at $92.06, with no clear ordering between short and long averages. RSI sits at 53.7, which reads as neutral, and MACD momentum is bullish. Watch $85.37 as support and $95.55 as the nearer resistance level.
On valuation the read is overvalued — earnings multiple of 36.5 versus a 17.0 sector average, above the peer group. Consensus targets land 15.3% above where the shares trade now. Revenue is growing at 26.3% on a 16.5% profit margin. The 0.38% dividend yield looks covered by current payout levels.
Risk scores 7 out of 10, which is elevated for this asset class. With 30-day volatility of 39.8%, a beta of 1.89 and a maximum drawdown of 18.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.

Top Market Events

Interactive Brokers IBKR delivered earnings and revenue surprises of +7.Interactive Brokers Group, Inc. IBKR closed the most recent trading day at $95.61, moving +2.19% from the previous...ADVFN23dInteractive Brokers beats Q2 forecasts on trading growth and higher interest income NASDAQ:IBKR Interactive...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading above the 200-day average of 77.10
  • MACD momentum is positive
  • Beta of 1.89 versus the benchmark

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 36.5 versus sector average of 17.0
  • Trading above the 200-day average of 77.10
  • Analyst targets imply +15.3% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 36.5 versus sector average of 17.0
  • Analyst targets imply +15.3% versus the current price
  • Profit margin of 16.5% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth26.30%
Profit Margin16.47%
P/E Ratio36.5
ROE24.02%
ROA2.28%
Debt/Equity205.75
P/B Ratio7.0
Op. Cash Flow$15.9B
Industry P/E17.0

Technical Analysis

TrendNeutral
RSI53.7
Support$85.37
Resistance$95.55
MA 20$90.28
MA 50$91.23
MA 200$77.10
MACDBullish
VolumeStable
Fear & Greed Index95.98

Valuation

Fair Value$280.38
Target Price$106.13
Upside/Downside15.29%
GradeOvervalued
TypeGrowth
Dividend Yield0.38%

Risk Assessment

Beta1.89
Volatility39.82%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.